744 related articles for article (PubMed ID: 27686401)
1. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis.
Aizawa N; Ishiuji Y; Tominaga M; Sakata S; Takahashi N; Yanaba K; Umezawa Y; Asahina A; Kimura U; Suga Y; Takamori K; Nakagawa H
J Immunol Res; 2019; 2019():8171373. PubMed ID: 30805373
[TBL] [Abstract][Full Text] [Related]
3. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
5. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
6. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
7. Assessment of IL-31 levels and disease severity in children with atopic dermatitis.
Ozceker D; Bulut M; Ozbay AC; Dilek F; Koser M; Tamay Z; Guler N
Allergol Immunopathol (Madr); 2018; 46(4):322-325. PubMed ID: 29555105
[TBL] [Abstract][Full Text] [Related]
8. Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis.
Kagami S; Sugaya M; Suga H; Morimura S; Kai H; Ohmatsu H; Fujita H; Tsunemi Y; Sato S
J Invest Dermatol; 2013 Jun; 133(6):1673-5. PubMed ID: 23353988
[No Abstract] [Full Text] [Related]
9. Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis.
Kawakami T; Kaminishi K; Soma Y; Kushimoto T; Mizoguchi M
J Dermatol Sci; 2006 Aug; 43(2):127-34. PubMed ID: 16843643
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of interleukin 33 in patients with atopic dermatitis.
Tamagawa-Mineoka R; Okuzawa Y; Masuda K; Katoh N
J Am Acad Dermatol; 2014 May; 70(5):882-8. PubMed ID: 24569114
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
Hon KL; Lam MC; Wong KY; Leung TF; Ng PC
Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670
[TBL] [Abstract][Full Text] [Related]
13. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
[TBL] [Abstract][Full Text] [Related]
14. Plasma endothelin-1 levels during exacerbation of atopic dermatitis.
Tsybikov NN; Petrisheva IV; Kuznik BI; Magen E
Allergy Asthma Proc; 2015; 36(4):320-4. PubMed ID: 26108089
[TBL] [Abstract][Full Text] [Related]
15. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M
Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
[TBL] [Abstract][Full Text] [Related]
16. Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus.
Teresiak-Mikołajczak E; Czarnecka-Operacz M; Jenerowicz D; Silny W
Postepy Dermatol Alergol; 2013 Oct; 30(5):286-92. PubMed ID: 24353488
[TBL] [Abstract][Full Text] [Related]
17. Plasma α-defensins are elevated during exacerbation of atopic dermatitis.
Tsybikov NN; Petrisheva IV; Fefelova EV; Kuznik BI; Magen E
Clin Exp Dermatol; 2016 Apr; 41(3):253-9. PubMed ID: 26411782
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of transcription factor PU.1 and interleukin-9 in atopic dermatitis and their relation to disease severity and eruption types.
Hamza AM; Omar SS; Abo El-Wafa RA; Elatrash MJ
Int J Dermatol; 2017 May; 56(5):534-539. PubMed ID: 28229452
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels.
Imaizumi A; Kawakami T; Murakami F; Soma Y; Mizoguchi M
J Dermatol Sci; 2003 Oct; 33(1):23-9. PubMed ID: 14527736
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
